• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Designing T cells for cancer immunotherapy.设计用于癌症免疫治疗的T细胞。
Discov Med. 2010 Apr;9(47):297-303.
2
Ex vivo gene transfer for improved adoptive immunotherapy of cancer.体外基因转移提高癌症过继免疫治疗。
Hum Mol Genet. 2011 Apr 15;20(R1):R93-9. doi: 10.1093/hmg/ddr102. Epub 2011 Mar 17.
3
Immunotherapy of human cancers using gene modified T lymphocytes.利用基因修饰 T 淋巴细胞进行人类癌症的免疫治疗。
Curr Gene Ther. 2009 Oct;9(5):396-408. doi: 10.2174/156652309789753338.
4
Adoptive T cell therapy of cancer.肿瘤的过继性细胞疗法。
Curr Opin Immunol. 2010 Apr;22(2):251-7. doi: 10.1016/j.coi.2010.01.020. Epub 2010 Feb 17.
5
Current status of genetic modification of T cells for cancer treatment.用于癌症治疗的T细胞基因改造的现状
Cytotherapy. 2005;7(3):262-72. doi: 10.1080/14653240510027217.
6
CAR T Cell Therapy for Solid Tumors.嵌合抗原受体 T 细胞疗法治疗实体瘤。
Annu Rev Med. 2017 Jan 14;68:139-152. doi: 10.1146/annurev-med-062315-120245. Epub 2016 Nov 17.
7
Mitochondrial transfer drives immune evasion in tumor microenvironment.线粒体转移促进肿瘤微环境中的免疫逃逸。
Trends Cancer. 2025 May;11(5):424-426. doi: 10.1016/j.trecan.2025.04.002. Epub 2025 Apr 22.
8
Adoptive immunotherapy with genetically modified lymphocytes in allogeneic stem cell transplantation.异基因造血干细胞移植中基因修饰淋巴细胞的过继免疫治疗。
Immunol Rev. 2014 Jan;257(1):165-80. doi: 10.1111/imr.12130.
9
Strategies to genetically engineer T cells for cancer immunotherapy.用于癌症免疫治疗的T细胞基因工程策略。
Cancer Immunol Immunother. 2016 Jun;65(6):631-49. doi: 10.1007/s00262-016-1842-5. Epub 2016 May 2.
10
Designing chimeric antigen receptors to effectively and safely target tumors.设计嵌合抗原受体以有效且安全地靶向肿瘤。
Curr Opin Immunol. 2015 Apr;33:9-15. doi: 10.1016/j.coi.2015.01.002. Epub 2015 Jan 23.

引用本文的文献

1
Long-Term Safety Follow-Up of Subjects Previously Treated with Non-Replicating Retroviral Vector-Based Gene Therapies.既往接受基于非复制逆转录病毒载体的基因治疗的受试者的长期安全性随访
Mol Diagn Ther. 2016 Dec;20(6):591-602. doi: 10.1007/s40291-016-0229-9.

本文引用的文献

1
Optimization of the PiggyBac transposon system for the sustained genetic modification of human T lymphocytes.优化 PiggyBac 转座子系统以实现人 T 淋巴细胞的持续遗传修饰。
J Immunother. 2009 Oct;32(8):826-36. doi: 10.1097/CJI.0b013e3181ad762b.
2
Fifteen years of gene therapy based on chimeric antigen receptors: "are we nearly there yet?".基于嵌合抗原受体的基因治疗 15 年:“我们快成功了吗?”。
Hum Gene Ther. 2009 Nov;20(11):1229-39. doi: 10.1089/hum.2009.142.
3
T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model.在霍奇金淋巴瘤模型中,共表达CCR4和靶向CD30的嵌合抗原受体的T淋巴细胞具有改善的归巢和抗肿瘤活性。
Blood. 2009 Jun 18;113(25):6392-402. doi: 10.1182/blood-2009-03-209650. Epub 2009 Apr 17.
4
Adoptive cell therapy for the treatment of patients with metastatic melanoma.过继性细胞疗法治疗转移性黑色素瘤患者
Curr Opin Immunol. 2009 Apr;21(2):233-40. doi: 10.1016/j.coi.2009.03.002. Epub 2009 Mar 21.
5
Genetic manipulation of tumor-specific cytotoxic T lymphocytes to restore responsiveness to IL-7.对肿瘤特异性细胞毒性T淋巴细胞进行基因操作以恢复对白细胞介素-7的反应性。
Mol Ther. 2009 May;17(5):880-8. doi: 10.1038/mt.2009.34. Epub 2009 Mar 3.
6
TCR transgenes and transgene cassettes for TCR gene therapy: status in 2008.用于TCR基因治疗的TCR转基因及转基因盒:2008年的现状
Cancer Immunol Immunother. 2009 May;58(5):809-22. doi: 10.1007/s00262-008-0649-4. Epub 2009 Feb 3.
7
Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma.经过基因工程改造以共表达肿瘤特异性受体的病毒特异性T细胞:在神经母细胞瘤患者中的持久性和抗肿瘤活性
Nat Med. 2008 Nov;14(11):1264-70. doi: 10.1038/nm.1882. Epub 2008 Nov 2.
8
How tumours escape mass destruction.肿瘤如何逃避大规模破坏。
Oncogene. 2008 Oct 6;27(45):5894-903. doi: 10.1038/onc.2008.268.
9
Cytotoxic T lymphocytes directed to the preferentially expressed antigen of melanoma (PRAME) target chronic myeloid leukemia.靶向黑色素瘤优先表达抗原(PRAME)的细胞毒性T淋巴细胞可针对慢性髓性白血病。
Blood. 2008 Sep 1;112(5):1876-85. doi: 10.1182/blood-2008-04-150045. Epub 2008 Jun 30.
10
Antitumor activity of EBV-specific T lymphocytes transduced with a dominant negative TGF-beta receptor.用显性负性转化生长因子-β受体转导的EBV特异性T淋巴细胞的抗肿瘤活性
J Immunother. 2008 Jun;31(5):500-5. doi: 10.1097/CJI.0b013e318177092b.

设计用于癌症免疫治疗的T细胞。

Designing T cells for cancer immunotherapy.

作者信息

Huye Leslie E, Dotti Gianpietro

机构信息

Center for Cell and Gene Therapy, Baylor College of Medicine, Houston 77030, United States.

出版信息

Discov Med. 2010 Apr;9(47):297-303.

PMID:20423673
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2931319/
Abstract

Adoptive transfer of T cells can enhance immune-mediated elimination of tumor cells and provides a specific, non-toxic cancer therapy. This approach has been effective in treating some hematologic and solid malignancies. In addition, the ability to genetically modify T cells to enhance their activity and persistence as well as overcome tumor immune evasion mechanisms has the potential to increase the success of these therapies in a wide range of tumors. In this review we discuss methods for gene transfer and specific modifications that have been made to T cells.

摘要

过继性转移T细胞可增强免疫介导的肿瘤细胞清除,并提供一种特异性、无毒的癌症治疗方法。这种方法在治疗某些血液系统恶性肿瘤和实体瘤方面已取得成效。此外,通过基因改造T细胞来增强其活性和持久性以及克服肿瘤免疫逃逸机制,有可能提高这些疗法在多种肿瘤中的成功率。在本综述中,我们讨论了T细胞基因转移方法和已进行的特异性改造。